In the News

Is fraud the business model of the prescription drug industry?

Geoff Riley

20th December 2016

Yes according to Democrat Bernie Sanders who is using the inter-regum between the Presidential election and the inauguration of Donald Trump to push his campaign alleging price gouging by the leading US pharmaceutical giants.

More here

I was struck in particular by an article in the FT that claimed the price of a routine anti-worming treatment is hundreds of times more expensive in the US than it is when paying over-the-counter in the UK. The brand Impax sells tapeworm treatment course for $880 v £3.50 in UK for the same treatment Ovex.

More here from the Guardian

Geoff Riley

Geoff Riley FRSA has been teaching Economics for over thirty years. He has over twenty years experience as Head of Economics at leading schools. He writes extensively and is a contributor and presenter on CPD conferences in the UK and overseas.

© 2002-2024 Tutor2u Limited. Company Reg no: 04489574. VAT reg no 816865400.